MedPath

The effect of N-acetylcysteine supplementation on cycling performance and adaptation to exercise in well-trained athletes

Phase 4
Conditions
Exercise adaptation
Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
Registration Number
ACTRN12609000804280
Lead Sponsor
niversity of Technology, Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

High level of physical fitness
Completed 10-15 h/wk physical training for at least 2 y in either cycling or triathlon

Exclusion Criteria

Regular antioxidant supplementation for previous 4 wks
Illness or injury which may be exacerbated through participation in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cycle ergometer performance time trial.[pre (day 1) and post (day 9) of each experimental period];Venous blood testing to determine changes total antioxidant status (TAS), glutathione/reduced glutathione ratio (GSSG:GSH), thiobarbituric acid-reactive substances (TBARS), interlukin-6 (IL-6), nuclear factor-kB and creatine kinase.[pre, immediately post, 2 h post and 24 h post each Cycle ergometer test]
Secondary Outcome Measures
NameTimeMethod
Training diaries and the Daily Analysis of Life Demands for Athletes[Completed on a daily basis during the experimental period]
© Copyright 2025. All Rights Reserved by MedPath